Latest News
18,033 Jobs and Continually Growing Exports in 2013 – Enterprise Ireland End of Year Statement
Connecting local suppliers to opportunities in the Construction Sector
Enterprise Ireland launches first online networking platform for female entrepreneurs
Research & Innovation
BLOODLINE – The Search for Speed
Irish Medical Device patented “Cool Brain” en route to Market
Comet chaser ‘Rosetta’ has technology from 2 Irish companies on board
Technology Centres – get the competitive edge that game-changing technology delivers
Start-ups, Jobs, Deals
Community Enterprise Centres create 9,300 jobs in the past decade
Online Media Hub PR Slides Raises €500k in Seed Funding and becomes a High Potential Start-Up
Glanbia to Create 90 Jobs in Monaghan and Dublin
International Activities
Gulf Trade Mission Creates 95 Jobs and €65m in Business Deals
200 International Buyers for Showcase - Ireland's Creative Expo
Global Sourcing – building bridges between indigenous and overseas firms
Meet the Buyer Event, Friday 31 January, The Heritage Hotel, Portlaoise.
Trade Mission to Singapore, 8-11 February 2014
The Start-up class of 2013 - Investor & Networking Morning, Wednesday 19 February, Dublin Castle
Twitter Feed
Contact Us  Follow Us
Research & Innovation

Irish Medical Device patented “Cool Brain” en route to Market
"Cool Brain" Product during the testing phase

Following Formula 1 driver Michael Schumacher’s recent skiing accident, brain trauma has been making headlines. An Irish company has developed a medical device that may be of significant benefit in cases of brain injury.  Eurolec Instrumentation Ltd’s ‘Cool Brain’ was designed to cool the brain at the earliest possible opportunity in the event of a stroke, heart attack or brain trauma to achieve the best possible prognosis.

Roughly 10,000 people suffer a stroke in Ireland each year, with this leading to 1,928 deaths in 2012 alone, according to the Central Statistics Office figures.  Understandably, research teams are keen to develop new treatment procedures aimed at reducing these figures, with mild therapeutic hypothermia considered one potential method.

Induced hypothermia has long been recognised as having neuroprotective benefits and is regularly used in the treatment of ischaemic stroke, cardiac arrest and traumatic brain injury. It is also used to assist babies who experience breathing difficulties at birth and to cool the scalp of chemotherapy patients to significantly reduce hair loss. Current research suggests that the main reason for its success is promoting anti-inflammatory responses that lower cerebral metabolic rate, which in turn reduces cell death at the site of injury. One of the big advantages is that the device is portable, operating from its own rechargeable battery which is key when the device is needed in an emergency situation and in ambulances. The ability to administer such a treatment, prior to hospital admission, could offer enormous benefits.

Using an Enterprise Ireland Innovation Voucher the company commissioned an independent evaluation of the device by a team from the Neuroscience Department in Trinity College Dublin under the leadership of Professor Shane O’Mara. Their full academic report runs to 17 pages and concluded that the device has considerable potential and could greatly benefit patients.

Eurolec Instrumentation (together with its associate company, Oriel Medical Devices Ltd) is keen to realise the full commercial potential of the patented device and is currently pitching to interested parties and is interested in hearing from organisations that have experience with medical devices and their route to market. For more information visit the company's website.

Email Newsletter Software by Newsweaver